Our global sites Open Search About us Our science Our products Investors Sustainability Careers Get in touch Strategy Allergy Therapeutics PLC Investment case Strategy Overview At a glance Financial highlights Investment case Business model Strategy Regulatory news Email alert Results, reports and presentations Financial Calendar Share tools Shareholder services AIM Rule 26 Corporate governance Investor and Advisor Contacts Our strategy is based on the three pillars of our business. 01 02 03 Expanding in Europe Strong pipeline US entry Strongly performing profitable business Growing existing market share, additional product registrations and entering new markets Drive market position by world-class supply chain and increased patient adherence New technologies underpin pipeline depth in convenient products Investment strategy supported by growing revenue streams Significant opportunity in largest allergy market Develop market access approach and relationships Secure funding for successful clinical development plans to deliver market access strategy Click for top of the page Linkedin icon Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement Contact us Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700 © Allergy Therapeutics 2021. By Emperor Cookie Control

Our global sites Open Search About us Our science Our products Investors Sustainability Careers Get in touch AGM information Allergy Therapeutics PLC Shareholder services AGM information Overview At a glance Financial highlights Investment case Regulatory news Email alert Results, reports and presentations Financial Calendar Share tools Shareholder services AGM information Registrar Details Major shareholders Analyst coverage Electronic communications AIM Rule 26 Corporate governance Investor and Advisor Contacts The 2021 Annual General Meeting (AGM) of Allergy Therapeutics plc was held on Monday 22 November 2022 at the offices of Panmure Gordon & Co, 1 New Change, London EC4M 9AF at 11:00 am. Full details of the results of the proxy voting on the resolutions put to the Annual General Meeting can be downloaded below. Documents relating to the meeting can be downloaded below: AGM 2021 Click for top of the page Linkedin icon Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement Contact us Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700 © Allergy Therapeutics 2021. By Emperor Cookie Control